Sort
34,240 grants matching “atherosclerosis”
THE ENDOTHELIAL PPARy-RXR TRANSCRIPTIONAL COMPLEX IN THE CONTROL OF METABOLISM
$390,847Jorge Plutzky · Brigham And Women'S Hospital · P01 · FY2013 · HL
Immunopathogenic features in calcific aortic stenosis
$390,828Robert Winchester · Columbia University Health Sciences · R01 · FY2008 · HL
Immunopathogenic features in calcific aortic stenosis
$390,828Robert Winchester · Columbia University Health Sciences · R01 · FY2009 · HL
Invasive Bacteria Accelerate Atherosclerosis through TLRs
$390,828Caroline A Genco · Boston Medical Center · R01 · FY2007 · HL
Apo B Translocation and Degradation
$390,784San Diego State University · R01 · FY2004 · HL
Stented Artery Wall Stresses and Retenosis
$390,775Texas A&M University System · R01 · FY2004 · EB
Stress and Platelet NPY in Vascular Remodeling
$390,755Zofia Zukowska · Georgetown University · R37 · FY2009 · HL
Urine Cadmium and Risk of Cardiovascular Disease
$390,743Jaymie R Meliker · State University New York Stony Brook · R01 · FY2020 · ES
Molecular Characterization of NoxA1 in VSMC NADPH Oxidase Activation
$390,743Marschall S. Runge · Univ Of North Carolina Chapel Hill · R01 · FY2013 · HL
Diabetes, Cognition and the Brain
$390,718New York University School Of Medicine · R01 · FY2004 · DK
Glutaminase in Arterial Injury and Disease
$390,685William Durante · University Of Missouri-Columbia · R01 · FY2021 · HL
Glutaminase in Arterial Injury and Disease
$390,685William Durante · University Of Missouri-Columbia · R01 · FY2023 · HL
Glutaminase in Arterial Injury and Disease
$390,685William Durante · University Of Missouri-Columbia · R01 · FY2024 · HL
Glutaminase in Arterial Injury and Disease
$390,685William Durante · University Of Missouri-Columbia · R01 · FY2022 · HL
Novel mechanisms for the generation of resolving monocytes
$390,684Liwu Li · Virginia Polytechnic Inst And St Univ · R01 · FY2024 · HL
MRP-14 and Cardiovascular Disease
$390,669Daniel I Simon · Case Western Reserve University · R01 · FY2008 · HL
Creating Glucose Responsive Cardiovascular Complications
$390,624Ira Jay Goldberg · Columbia University Health Sciences · U01 · FY2010 · HL
IGF::OT::IGF MESA - TOPMED - 08/04/2016 - 12/31/2016
$390,622Robyn McClelland · University Of Washington · N01 · FY2016 · HL
Mechanisms of Pannexin Channel Activation in Physiology and Cell Death
$390,568Douglas A Bayliss · University Of Virginia · P01 · FY2017 · HL
Mechanisms of Pannexin Channel Activation in Physiology and Cell Death
$390,568Douglas A Bayliss · University Of Virginia · P01 · FY2016 · HL
Mechanisms of Pannexin Channel Activation in Physiology and Cell Death
$390,568Douglas A Bayliss · University Of Virginia · P01 · FY2014 · HL
Mechanisms of Pannexin Channel Activation in Physiology and Cell Death
$390,568Douglas A Bayliss · University Of Virginia · P01 · FY2018 · HL
Metabolic complications of HIV disease caused by Nef released from HIV-infected cells
$390,491Michael Ilya Bukrinsky · George Washington University · R01 · FY2018 · HL
Spectroscopic Studies of Mononuclear Non-Heme Fe Enzymes
$390,488Edward I Solomon · Stanford University · R01 · FY2014 · GM
Vitamin D Intervention and Atherosclerosis Progression in African American Women
$390,445Howard N Hodis · University Of Southern California · R01 · FY2012 · HL